Moderate Severe Hypoxic Ischaemic Encephalopathy Hie clinical trials

Explore recruiting moderate severe hypoxic ischaemic encephalopathy hie clinical trials.

Recruiting moderate severe hypoxic ischaemic encephalopathy hie studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate Severe Hypoxic Ischaemic Encephalopathy Hie trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ACUMEN: Phase I Dose Escalation and Cohort Expansion study to affirm the safety of pharmacological doses of a novel formulation of intravenous melatonin in babies with hypoxic-ischaemic encephalopathy (HIE) to augment therapeutic hypothermia (HT) treatment; to reduce the incidence and severity of disability in babies with moderate-severe HIE.

Ireland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Moderate Severe Hypoxic Ischaemic Encephalopathy Hie trials by city

Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Toronto Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Vancouver Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Montreal Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Calgary Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Edmonton Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Ottawa Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Winnipeg Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Quebec City Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Hamilton Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Kitchener Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in London Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Halifax Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in New York Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Los Angeles Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Chicago Moderate Severe Hypoxic Ischaemic Encephalopathy Hie in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease